Tianti Biotherapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15.7M
- Investors
-
5
Tianti Biotherapeutics General Information
Description
Developer of a drug discovery platform designed to improve the efficiency of antibody development. The company's platform utilizes proprietary technology to screen and build libraries of tens of millions of single B cells, enabling drug companies to improve the quality of new antibody development for muscular dystrophy and cancer.
Contact Information
Website
www.ttibio.comCorporate Office
- A2-328
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215000
- China
Corporate Office
- A2-328
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215000
- China
Tianti Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 13-Dec-2021 | $15.7M | Completed | Generating Revenue | ||
| 1. Seed Round | 12-May-2021 | Completed | Startup |
Tianti Biotherapeutics Signals
Tianti Biotherapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Guangzhou Yuexiu Industrial Investment Fund Management | PE/Buyout | Minority | ||
| Shanghai Healthcare Capital | PE/Buyout | Minority | ||
| Shangshi Venture Investment | Corporate Venture Capital | Minority | ||
| Suzhou Oriza Holdings Corporation | Asset Manager | Minority | ||
| Kaitai Capital | Venture Capital | Minority |
Tianti Biotherapeutics FAQs
-
When was Tianti Biotherapeutics founded?
Tianti Biotherapeutics was founded in 2021.
-
Where is Tianti Biotherapeutics headquartered?
Tianti Biotherapeutics is headquartered in Suzhou, China.
-
What is the size of Tianti Biotherapeutics?
Tianti Biotherapeutics has 12 total employees.
-
What industry is Tianti Biotherapeutics in?
Tianti Biotherapeutics’s primary industry is Drug Discovery.
-
Is Tianti Biotherapeutics a private or public company?
Tianti Biotherapeutics is a Private company.
-
What is Tianti Biotherapeutics’s current revenue?
The current revenue for Tianti Biotherapeutics is .
-
How much funding has Tianti Biotherapeutics raised over time?
Tianti Biotherapeutics has raised $16.4M.
-
Who are Tianti Biotherapeutics’s investors?
Guangzhou Yuexiu Industrial Investment Fund Management, Shanghai Healthcare Capital, Shangshi Venture Investment, Suzhou Oriza Holdings Corporation, and Kaitai Capital have invested in Tianti Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process